AstraZeneca COVID-19 Vaccine (ChAdOx1-S [Recombinant]) Vaccine National Protocol

This protocol is for the supply and administration of AstraZeneca COVID-19 Vaccine (ChAdOx1-S [Recombinant]) to individuals in accordance with the national COVID-19 vaccination programme.


AstraZeneca COVID-19 Vaccine (ChAdOx1-S [Recombinant]) Vaccine National Protocol

Reference no: AstraZeneca COVID-19 Vaccine (ChAdOx1-S [Recombinant]) Vaccine Protocol

Version no: v02.1

Valid from: 22 February 2021

Review date: 30 November 2021

Expiry date: 31 December 2021

Contact

Email: Covid19VaccinePolicyMailbox@gov.scot

Back to top